HMGB1 and colorectal carcinoma: As relatively high glutaminolytic rates yielding glutamine-derived lactate (Fig. 7c) defined HMGB1-resistant CRC cells in our model, we focused on the ME1 that enables the final conversion of glutamine to lactate by catalysing the oxidation of malate to pyruvate.